Published in BMC Genomics on November 22, 2001
A complex containing the CCR4 and CAF1 proteins is involved in mRNA deadenylation in Drosophila. EMBO J (2004) 2.40
Deadenylation is prerequisite for P-body formation and mRNA decay in mammalian cells. J Cell Biol (2008) 1.98
PPARγ: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol (2010) 1.72
Mechanisms of deadenylation-dependent decay. Wiley Interdiscip Rev RNA (2010) 1.69
Human Ccr4-Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription. EMBO J (2006) 1.69
UNR, a new partner of poly(A)-binding protein, plays a key role in translationally coupled mRNA turnover mediated by the c-fos major coding-region determinant. Genes Dev (2004) 1.52
Subunits of the Drosophila CCR4-NOT complex and their roles in mRNA deadenylation. RNA (2010) 1.51
A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-gamma nuclear translocation. Proc Natl Acad Sci U S A (2010) 1.46
A role for Caf1 in mRNA deadenylation and decay in trypanosomes and human cells. Nucleic Acids Res (2008) 1.46
Tethering KSRP, a decay-promoting AU-rich element-binding protein, to mRNAs elicits mRNA decay. Mol Cell Biol (2006) 1.44
Ccr4-Not complex: the control freak of eukaryotic cells. Crit Rev Biochem Mol Biol (2012) 1.43
Conservation of the deadenylase activity of proteins of the Caf1 family in human. RNA (2005) 1.38
Crystal structure of the human CNOT6L nuclease domain reveals strict poly(A) substrate specificity. EMBO J (2010) 1.33
Circadian control of messenger RNA stability. Association with a sequence-specific messenger RNA decay pathway. Plant Physiol (2005) 1.28
Human Pumilio proteins recruit multiple deadenylases to efficiently repress messenger RNAs. J Biol Chem (2012) 1.27
Immediate early response of the circadian polyA ribonuclease nocturnin to two extracellular stimuli. RNA (2007) 1.27
The structural basis for the interaction between the CAF1 nuclease and the NOT1 scaffold of the human CCR4-NOT deadenylase complex. Nucleic Acids Res (2012) 1.19
An unconventional human Ccr4-Caf1 deadenylase complex in nuclear cajal bodies. Mol Cell Biol (2006) 1.17
The Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferation. Mol Biol Cell (2009) 1.14
CCR4-associated factor CAF1 is an essential factor for spermatogenesis. Mol Cell Biol (2004) 1.13
The structural basis for deadenylation by the CCR4-NOT complex. Protein Cell (2010) 1.13
The Ccr4a (CNOT6) and Ccr4b (CNOT6L) deadenylase subunits of the human Ccr4-Not complex contribute to the prevention of cell death and senescence. Mol Biol Cell (2011) 1.11
NOT10 and C2orf29/NOT11 form a conserved module of the CCR4-NOT complex that docks onto the NOT1 N-terminal domain. RNA Biol (2013) 1.09
mRNA deadenylation by PARN is essential for embryogenesis in higher plants. RNA (2004) 1.01
Cytoplasmic and nuclear quality control and turnover of single-stranded RNA modulate post-transcriptional gene silencing in plants. Nucleic Acids Res (2013) 1.00
Obesity resistance and increased hepatic expression of catabolism-related mRNAs in Cnot3+/- mice. EMBO J (2011) 1.00
Nocturnin: at the crossroads of clocks and metabolism. Trends Endocrinol Metab (2012) 0.97
Skeletal aging and the adipocyte program: New insights from an "old" molecule. Cell Cycle (2010) 0.97
Curled encodes the Drosophila homolog of the vertebrate circadian deadenylase Nocturnin. Genetics (2009) 0.93
Deadenylation of mRNA by the CCR4-NOT complex in Drosophila: molecular and developmental aspects. Front Genet (2014) 0.91
Evidence providing new insights into TOB-promoted deadenylation and supporting a link between TOB's deadenylation-enhancing and antiproliferative activities. Mol Cell Biol (2012) 0.91
Insights into the structure and architecture of the CCR4-NOT complex. Front Genet (2014) 0.87
Tracking a refined eIF4E-binding motif reveals Angel1 as a new partner of eIF4E. Nucleic Acids Res (2013) 0.86
Multifunctional roles of the mammalian CCR4-NOT complex in physiological phenomena. Front Genet (2014) 0.84
Kiss your tail goodbye: the role of PARN, Nocturnin, and Angel deadenylases in mRNA biology. Biochim Biophys Acta (2012) 0.84
A fluorescence-based assay suitable for quantitative analysis of deadenylase enzyme activity. Nucleic Acids Res (2013) 0.83
Heterogeneity and complexity within the nuclease module of the Ccr4-Not complex. Front Genet (2013) 0.82
Saccharomyces cerevisiae Ngl3p is an active 3'-5' exonuclease with a specificity towards poly-A RNA reminiscent of cellular deadenylases. Nucleic Acids Res (2011) 0.82
The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4-Not nuclease module. Biochem J (2015) 0.82
The circadian deadenylase Nocturnin is necessary for stabilization of the iNOS mRNA in mice. PLoS One (2011) 0.82
Deadenylation and P-bodies. Adv Exp Med Biol (2013) 0.79
RNA Quality Control as a Key to Suppressing RNA Silencing of Endogenous Genes in Plants. Mol Plant (2016) 0.78
Important miRs of pathways in different tumor types. PLoS Comput Biol (2013) 0.76
Regulation of mRNA decay in plant responses to salt and osmotic stress. Cell Mol Life Sci (2016) 0.75
AtHESPERIN: a novel regulator of circadian rhythms with poly(A)-degrading activity in plants. RNA Biol (2016) 0.75
RNA processing and modification protein, carbon catabolite repression 4 (Ccr4), arrests the cell cycle through p21-dependent and p53-independent pathway. J Biol Chem (2012) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res (1988) 7.28
The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell (2001) 5.86
Structure and function of the multifunctional DNA-repair enzyme exonuclease III. Nature (1995) 3.00
Identification of new genes involved in the regulation of yeast alcohol dehydrogenase II. Genetics (1984) 2.81
A complex containing RNA polymerase II, Paf1p, Cdc73p, Hpr1p, and Ccr4p plays a role in protein kinase C signaling. Mol Cell Biol (1999) 2.80
The NOT proteins are part of the CCR4 transcriptional complex and affect gene expression both positively and negatively. EMBO J (1998) 2.78
The yeast POP2 gene encodes a nuclease involved in mRNA deadenylation. Nucleic Acids Res (2001) 2.76
Structure of DNase I at 2.0 A resolution suggests a mechanism for binding to and cutting DNA. Nature (1986) 2.73
The crystal structure of the human DNA repair endonuclease HAP1 suggests the recognition of extra-helical deoxyribose at DNA abasic sites. EMBO J (1997) 2.53
Structural and functional diversity in the leucine-rich repeat family of proteins. Prog Biophys Mol Biol (1996) 2.43
Poly(A) tail shortening by a mammalian poly(A)-specific 3'-exoribonuclease. J Biol Chem (1997) 2.38
Suppression of a new allele of the yeast RAD52 gene by overexpression of RAD51, mutations in srs2 and ccr4, or mating-type heterozygosity. Genetics (1995) 2.33
Isolation and characterization of human orthologs of yeast CCR4-NOT complex subunits. Nucleic Acids Res (2000) 2.13
Identification of a mouse protein whose homolog in Saccharomyces cerevisiae is a component of the CCR4 transcriptional regulatory complex. Mol Cell Biol (1995) 1.95
The CCR4 and CAF1 proteins of the CCR4-NOT complex are physically and functionally separated from NOT2, NOT4, and NOT5. Mol Cell Biol (1999) 1.94
CCR4 is a glucose-regulated transcription factor whose leucine-rich repeat binds several proteins important for placing CCR4 in its proper promoter context. Mol Cell Biol (1994) 1.90
Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. Proc Natl Acad Sci U S A (2000) 1.88
Functionally unrelated signalling proteins contain a fold similar to Mg2+-dependent endonucleases. Trends Biochem Sci (2000) 1.85
DBF2, a cell cycle-regulated protein kinase, is physically and functionally associated with the CCR4 transcriptional regulatory complex. EMBO J (1997) 1.85
Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway. J Biol Chem (2001) 1.79
Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene (1999) 1.54
Characterization of CAF4 and CAF16 reveals a functional connection between the CCR4-NOT complex and a subset of SRB proteins of the RNA polymerase II holoenzyme. J Biol Chem (2000) 1.51
The CCR4 protein from Saccharomyces cerevisiae contains a leucine-rich repeat region which is required for its control of ADH2 gene expression. Genetics (1992) 1.49
Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1999) 1.47
Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. J Biol Chem (1998) 1.41
Identification of a novel vertebrate circadian clock-regulated gene encoding the protein nocturnin. Proc Natl Acad Sci U S A (1996) 1.40
Site-directed mutagenesis of the human DNA repair enzyme HAP1: identification of residues important for AP endonuclease and RNase H activity. Nucleic Acids Res (1995) 1.34
Human carbon catabolite repressor protein (CCR4)-associative factor 1: cloning, expression and characterization of its interaction with the B-cell translocation protein BTG1. Biochem J (1998) 1.30
The centromere and promoter factor, 1, CPF1, of Saccharomyces cerevisiae modulates gene activity through a family of factors including SPT21, RPD1 (SIN3), RPD3 and CCR4. Mol Gen Genet (1993) 1.29
Association of distinct yeast Not2 functional domains with components of Gcn5 histone acetylase and Ccr4 transcriptional regulatory complexes. EMBO J (1998) 1.11
Characterization of a mammalian gene related to the yeast CCR4 general transcription factor and revealed by transposon insertion. J Biol Chem (1999) 1.05
Identification of a novel Drosophila melanogaster gene, angel, a member of a nested gene cluster at locus 59F4,5. Biochim Biophys Acta (1996) 0.88
The human POP2 gene: identification, sequencing, and mapping to the critical region of the 5q- syndrome. Genomics (1999) 0.87
Alu polymerase chain reaction: a method for rapid isolation of human-specific sequences from complex DNA sources. Proc Natl Acad Sci U S A (1989) 8.68
Human LINE retrotransposons generate processed pseudogenes. Nat Genet (2000) 6.64
The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation. J Biol Chem (2000) 5.56
Taming of transposable elements by homology-dependent gene silencing. Nat Genet (1999) 3.86
Retrotransposition of a mouse IAP sequence tagged with an indicator gene. Cell (1991) 2.34
Structural and functional properties of the acetylcholine receptor protein in its purified and membrane-bound states. Annu Rev Biochem (1978) 2.19
mRNA retroposition in human cells: processed pseudogene formation. EMBO J (1995) 2.15
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the delta subunit is labeled by [3H]chlorpromazine. Proc Natl Acad Sci U S A (1986) 2.06
Identification, phylogeny, and evolution of retroviral elements based on their envelope genes. J Virol (2001) 1.91
Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway. J Biol Chem (2001) 1.79
An indicator gene for detection of germline retrotransposition in transgenic Drosophila demonstrates RNA-mediated transposition of the LINE I element. EMBO J (1991) 1.75
Distinct protein components from Torpedo marmorata membranes carry the acetylcholine receptor site and the binding site for local anesthetics and histrionicotoxin. Proc Natl Acad Sci U S A (1978) 1.71
ERV-L elements: a family of endogenous retrovirus-like elements active throughout the evolution of mammals. J Virol (1999) 1.70
Members of the SRY family regulate the human LINE retrotransposons. Nucleic Acids Res (2000) 1.69
Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata. Biochemistry (1983) 1.64
Human endogenous retroviruses: from infectious elements to human genes. Cytogenet Genome Res (2005) 1.64
Isolation of novel human endogenous retrovirus-like elements with foamy virus-related pol sequence. J Virol (1995) 1.62
Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc Natl Acad Sci U S A (1998) 1.60
From ancestral infectious retroviruses to bona fide cellular genes: role of the captured syncytins in placentation. Placenta (2012) 1.59
Germ line-specific expression of intracisternal A-particle retrotransposons in transgenic mice. Mol Cell Biol (1996) 1.52
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3H]chlorpromazine labels homologous residues in the beta and delta chains. Biochemistry (1987) 1.45
Physiological knockout of the envelope gene of the single-copy ERV-3 human endogenous retrovirus in a fraction of the Caucasian population. J Virol (1998) 1.44
Functional differences between the human LINE retrotransposon and retroviral reverse transcriptases for in vivo mRNA reverse transcription. EMBO J (1997) 1.42
Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. J Biol Chem (1998) 1.41
Generation of processed pseudogenes in murine cells. EMBO J (1993) 1.37
Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome. J Gen Virol (1996) 1.35
The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive properties. J Gen Virol (2001) 1.26
Regulatory role of a monomorphic determinant of HLA Class I antigens in T cell proliferation. J Immunol (1985) 1.23
Fast kinetic studies on the interaction of a fluorescent agonist with the membrane-bound acetylcholine receptor from Torpedo marmorata. Eur J Biochem (1979) 1.21
Defective retroviruses can disperse in the human genome by intracellular transposition. J Virol (1991) 1.19
Defective I elements introduced into Drosophila as transgenes can regulate reactivity and prevent I-R hybrid dysgenesis. Mol Gen Genet (1995) 1.19
Fast kinetic studies on the allosteric interactions between acetylcholine receptor and local anesthetic binding sites. Eur J Biochem (1979) 1.18
Characterization of the three HERV-H proviruses with an open envelope reading frame encompassing the immunosuppressive domain and evolutionary history in primates. Virology (2001) 1.17
Expression of the fusogenic HERV-FRD Env glycoprotein (syncytin 2) in human placenta is restricted to villous cytotrophoblastic cells. Placenta (2006) 1.15
A truncated form of the human CAF-1 p150 subunit impairs the maintenance of transcriptional gene silencing in mammalian cells. Mol Cell Biol (2001) 1.14
A nuclear matrix/scaffold attachment region co-localizes with the gypsy retrotransposon insulator sequence. J Biol Chem (1998) 1.14
LINEs, SINEs and processed pseudogenes: parasitic strategies for genome modeling. Cytogenet Genome Res (2005) 1.13
Interaction of a fluorescent agonist with the membrane-bound acetylcholine receptor from Torpedo marmorata in the millisecond time range: resolution of an "intermediate" conformational transition and evidence for positive cooperative effects. Biochem Biophys Res Commun (1980) 1.12
BTG gene expression in the p53-dependent and -independent cellular response to DNA damage. Mol Carcinog (2000) 1.12
Multiple affinity states for noncompetitive blockers revealed by [3H]phencyclidine binding to acetylcholine receptor rich membrane fragments from Torpedo marmorata. Biochemistry (1983) 1.10
The envelope of Mason-Pfizer monkey virus has immunosuppressive properties. J Gen Virol (2001) 1.09
Cosuppression of I transposon activity in Drosophila by I-containing sense and antisense transgenes. Genetics (1999) 1.09
Rapid kinetics of agonist binding and permeability response analyzed in parallel on acetylcholine receptor rich membranes from Torpedo marmorata. Biochemistry (1983) 1.08
Characterization of a mammalian gene related to the yeast CCR4 general transcription factor and revealed by transposon insertion. J Biol Chem (1999) 1.05
Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice. Oncogene (1997) 1.04
Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. Cancer Res (1994) 1.02
Reconstitution of a functional acetylcholine receptor. Conservation of the conformational and allosteric transitions and recovery of the permeability response; role of lipids. Eur J Biochem (1980) 1.02
High-frequency intracellular transposition of a defective mammalian provirus detected by an in situ colorimetric assay. J Virol (1992) 1.00
[Molecular model of the regulation of chemical synapse efficiency at the postsynaptic level]. C R Seances Acad Sci III (1982) 0.99
Characterization of the transient agonist-triggered state of the acetylcholine receptor rapidly labeled by the noncompetitive blocker [3H]chlorpromazine: additional evidence for the open channel conformation. Biochemistry (1986) 0.99
Evidence for a reverse transcription intermediate for a marked line transposon in tumoral rat cells. Biochem Biophys Res Commun (1991) 0.97
Time-resolved photolabeling by the noncompetitive blocker chlorpromazine of the acetylcholine receptor in its transiently open and closed ion channel conformations. Proc Natl Acad Sci U S A (1984) 0.96
Identification of a strong transcriptional activator for the copia retrotransposon responsible for its differential expression in Drosophila hydei and melanogaster cell lines. Biochem Biophys Res Commun (1994) 0.96
Reconstitution of a functional acetylcholine receptor. Polypeptide chains, ultrastructure, and binding sites for acetylcholine and local anesthetics. Eur J Biochem (1980) 0.95
AF15q14, a novel partner gene fused to the MLL gene in an acute myeloid leukaemia with a t(11;15)(q23;q14). Oncogene (2000) 0.94
Molecular cloning and characterization of a transcription factor for the copia retrotransposon with homology to the BTB-containing lola neurogenic factor. Mol Cell Biol (1997) 0.94
Reconstitution of a functional acetylcholine regulator under defined conditions. FEBS Lett (1979) 0.93
The long terminal repeats of the HERV-H human endogenous retrovirus contain binding sites for transcriptional regulation by the Myb protein. J Gen Virol (1999) 0.91
A syncytin-like endogenous retrovirus envelope gene of the guinea pig specifically expressed in the placenta junctional zone and conserved in Caviomorpha. Placenta (2011) 0.91
Retrotransposition of a marked Drosophila line-like I element in cells in culture. Nucleic Acids Res (1994) 0.90
IAP retrotransposons in the mouse liver as reporters of ageing. Biochim Biophys Acta (1995) 0.90
Methylation, a key step for nongenomic estrogen signaling in breast tumors. Steroids (2010) 0.89
Characterization of two age-induced intracisternal A-particle-related transcripts in the mouse liver. Transcriptional read-through into an open reading frame with similarities to the yeast ccr4 transcription factor. J Biol Chem (1997) 0.88
[The high affinity binding site for chlorpromazine is present only as a single copy per cholinergic receptor molecule and is shared by four polypeptide chains]. C R Seances Acad Sci III (1982) 0.88
The Drosophila copia retrotransposon contains binding sites for transcriptional regulation by homeoproteins. Nucleic Acids Res (1993) 0.87
Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation. J Immunol (1987) 0.85
Response of plasma lipids and platelet aggregation to intravenous arginine. Proc Soc Exp Biol Med (1973) 0.84
Retrotransposition of the Drosophila LINE I element can induce deletion in the target DNA: a simple model also accounting for the variability of the normally observed target site duplications. Biochem Biophys Res Commun (1994) 0.84
[Study by a rapid mixing method of the interaction between a fluorescent cholinergic agonist and membrane fragments rich in cholinergic receptors from Torpedo marmorata]. C R Acad Sci Hebd Seances Acad Sci D (1977) 0.84
[Selective stabilization of neuronal representations by resonance between spontaneous prerepresentations of the cerebral network and percepts evoked by interaction with the outside world]. C R Acad Sci III (1984) 0.84
Protein-bound plasma homocyst(e)ine and identification of heterozygotes for cystathionine-synthase deficiency. J Inherit Metab Dis (1986) 0.81
Assessment of transformed properties in vitro and of tumorigenicity in vivo in primary keratinocytes cultured for epidermal sheet transplantation. J Skin Cancer (2010) 0.80
Polyenoic acid metabolism in cultured human skin fibroblasts. Lipids (1978) 0.80
Enhancing effect of anti-HLA class I monoclonal antibodies on T cell proliferation induced via CD2 molecule. J Immunol (1988) 0.80
Increased fetal insulin receptors and changes in membrane fluidity and lipid composition. Am J Physiol (1982) 0.79
FLRG, an activin-binding protein, is a new target of TGFbeta transcription activation through Smad proteins. Oncogene (2001) 0.79
Allosteric properties of the acetylcholine receptor protein from Torpedo marmorata. Cold Spring Harb Symp Quant Biol (1983) 0.78
Plasma fatty acids in pancreatic cystic fibrosis and liver disease. J Clin Endocrinol Metab (1966) 0.78
Transferrin-like autocrine growth factor, derived from T-lymphoma cells, that inhibits normal T-cell proliferation. Cancer Res (1988) 0.78
ERV-3 envelope expression and congenital heart block: what does a physiological knockout teach us. Autoimmunity (1999) 0.78
Functional assay of tRNA molecules transcribed from a purified gene. Nucleic Acids Res (1982) 0.77
Inhibition by anti-HLA class I mAb of IL-2 and IL-2 receptor synthesis in lymphocytes stimulated with PHA-P. Cell Immunol (1990) 0.76
[Isolation by density gradient of a fraction of rat hepatocytes intervening chiefly in compensatory hypertrophy]. Exp Cell Res (1969) 0.76
Transfer of plasma lipid to platelets by action of glucagon. Metabolism (1970) 0.76
Oxygen consumption and guanosine diphosphate binding by fetal brown adipose tissue in diabetic pregnancy. Metabolism (1989) 0.76
[Purification of a protein binding quinacrine and histrionicotoxin from membrane fragments rich in cholinergic receptors in Torpedo marmorata]. C R Acad Sci Hebd Seances Acad Sci D (1977) 0.76
Glucagon and plasma lipoprotein lipase. Proc Soc Exp Biol Med (1974) 0.76
Structural and functional properties of the acetylcholine regulator. Adv Cytopharmacol (1979) 0.76
Allosteric effects of diprobutine on acetylcholine receptors. Eur J Pharmacol (1985) 0.75
Amniotic fluid microviscosity analysis in diabetic pregnancies: comparison with other methods of lung maturity assessment using predictive value analyses. Mt Sinai J Med (1985) 0.75
Lymphocyte proliferative response to mitogenic monoclonal antibodies in systemic sclerosis. Evidence for unresponsiveness to murine monoclonal antibodies of IgG1 isotype. Tissue Antigens (1989) 0.75